BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37292897)

  • 41. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation.
    Schwinger RH; Münch G; Bölck B; Karczewski P; Krause EG; Erdmann E
    J Mol Cell Cardiol; 1999 Mar; 31(3):479-91. PubMed ID: 10198180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sarcolipin and phospholamban inhibit the calcium pump by populating a similar metal ion-free intermediate state.
    Espinoza-Fonseca LM; Autry JM; Thomas DD
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):37-41. PubMed ID: 25983321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Phosphorylation on Interactions between Transmembrane Domains of SERCA and Phospholamban.
    Martin PD; James ZM; Thomas DD
    Biophys J; 2018 Jun; 114(11):2573-2583. PubMed ID: 29874608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: a new role for phospholipids in the regulation of cardiac calcium cycling?
    Hughes E; Clayton JC; Middleton DA
    Biochim Biophys Acta; 2009 Feb; 1788(2):559-66. PubMed ID: 19059204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump.
    Trieber CA; Afara M; Young HS
    Biochemistry; 2009 Oct; 48(39):9287-96. PubMed ID: 19708671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solid-state (2)H and (15)N NMR studies of side-chain and backbone dynamics of phospholamban in lipid bilayers: investigation of the N27A mutation.
    Chu S; Coey AT; Lorigan GA
    Biochim Biophys Acta; 2010 Feb; 1798(2):210-5. PubMed ID: 19840770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation state-dependent interaction between AKAP7δ/γ and phospholamban increases phospholamban phosphorylation.
    Rigatti M; Le AV; Gerber C; Moraru II; Dodge-Kafka KL
    Cell Signal; 2015 Sep; 27(9):1807-15. PubMed ID: 26027516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Phospholamban Pentamer Alters Function of the Sarcoplasmic Reticulum Calcium Pump SERCA.
    Glaves JP; Primeau JO; Espinoza-Fonseca LM; Lemieux MJ; Young HS
    Biophys J; 2019 Feb; 116(4):633-647. PubMed ID: 30712785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase.
    Karim CB; Marquardt CG; Stamm JD; Barany G; Thomas DD
    Biochemistry; 2000 Sep; 39(35):10892-7. PubMed ID: 10978176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-Color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding.
    Hou Z; Hu Z; Blackwell DJ; Miller TD; Thomas DD; Robia SL
    PLoS One; 2012; 7(7):e40369. PubMed ID: 22808146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
    Posch MG; Perrot A; Geier C; Boldt LH; Schmidt G; Lehmkuhl HB; Hetzer R; Dietz R; Gutberlet M; Haverkamp W; Ozcelik C
    Heart Rhythm; 2009 Apr; 6(4):480-6. PubMed ID: 19324307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure.
    Currie S; Smith GL
    Cardiovasc Res; 1999 Jan; 41(1):135-46. PubMed ID: 10325961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular noise filtering in the β-adrenergic signaling network by phospholamban pentamers.
    Koch D; Alexandrovich A; Funk F; Kho AL; Schmitt JP; Gautel M
    Cell Rep; 2021 Jul; 36(4):109448. PubMed ID: 34320358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban.
    Thomas DD; Reddy LG; Karim CB; Li M; Cornea R; Autry JM; Jones LR; Stamm J
    Ann N Y Acad Sci; 1998 Sep; 853():186-94. PubMed ID: 10603946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of DWORF does not affect cardiac function in aging and in PLN-R14del cardiomyopathy.
    Stege NM; Oliveira Nunes Teixeira V; Zijlstra SN; Feringa AM; de Boer RA; Silljé HHW
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H870-H876. PubMed ID: 38334971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atomic-level mechanisms for phospholamban regulation of the calcium pump.
    Espinoza-Fonseca LM; Autry JM; Ramírez-Salinas GL; Thomas DD
    Biophys J; 2015 Apr; 108(7):1697-1708. PubMed ID: 25863061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes.
    Hellstern S; Pegoraro S; Karim CB; Lustig A; Thomas DD; Moroder L; Engel J
    J Biol Chem; 2001 Aug; 276(33):30845-52. PubMed ID: 11413134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure.
    Lockamy EL; Cornea RL; Karim CB; Thomas DD
    Biochem Biophys Res Commun; 2011 May; 408(3):388-92. PubMed ID: 21510919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced sarcoplasmic reticulum Ca2+ uptake and increased Na+-Ca2+ exchanger expression in left ventricle myocardium of dogs with progression of heart failure.
    Mishra S; Sabbah HN; Rastogi S; Imai M; Gupta RC
    Heart Vessels; 2005 Feb; 20(1):23-32. PubMed ID: 15700199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SR Ca(2+)-ATPase/phospholamban in cardiomyocyte function.
    Tada M; Toyofuku T
    J Card Fail; 1996 Dec; 2(4 Suppl):S77-85. PubMed ID: 8951564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.